SCHEMBL3174496

SCHEMBL3174496

CC(=O)NCCNc1cc(NC(=O)C(=O)N2CCN(c3ccccn3)CC2)nc(-c2ccccc2)n1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.45
▸ MAPK1 P28482 2/20 0.45
▸ SLC6A7 Q99884 1/20 0.45
▸ L3MBTL1 Q9Y468 1/20 0.45
▸ KDM4E B2RXH2 5/20 0.43
▸ POLB P06746 3/20 0.43
▸ HPGD P15428 2/20 0.43
▸ CYP3A4 P08684 1/20 0.43
▸ CYP2C9 P11712 1/20 0.43
▸ RECQL P46063 1/20 0.43
▸ HSD17B10 Q99714 1/20 0.43
▸ PHGDH O43175 1/20 0.42
▸ KDM6A O15550 1/20 0.41
▸ KDM5A P29375 1/20 0.41
▸ TSHR P16473 2/20 0.41
▸ MEN1 O00255 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ LMNA P02545 1/20 0.41
▸ RCE1 Q9Y256 1/20 0.41
▸ ADORA3 P0DMS8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3163421 0.89 HTR1A (0.44) ALDH1A1LMNAADORA3ADORA2AADORA2B
SCHEMBL3166495 0.88 SLC1A2 (0.44) ALDH1A1MAPK1SLC6A7KDM4EPOLB
SCHEMBL3175769 0.87 ADORA2A (0.45) ALDH1A1MAPK1KDM4ECYP3A4RECQL
SCHEMBL3164671 0.87 ADORA2A (0.41) ALDH1A1MAPK1CYP3A4HSD17B10TSHR
SCHEMBL3155892 0.86 ADORA2A (0.46) ALDH1A1MAPK1KDM4ECYP3A4RECQL
SCHEMBL3162937 0.86 ADORA2A (0.46) ALDH1A1MAPK1KDM4ECYP3A4RECQL
SCHEMBL3172350 0.86 THRB (0.55) ALDH1A1L3MBTL1KDM4EPOLBCYP3A4
SCHEMBL3165279 0.86 CYP1A2 (0.43) ALDH1A1MAPK1CYP3A4CYP2C9HSD17B10
SCHEMBL3166225 0.85 ADORA2A (0.45) ALDH1A1MAPK1KDM4ECYP3A4CYP2C9
SCHEMBL3174594 0.85 ADORA2A (0.45) ALDH1A1MAPK1KDM4ECYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-B1 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2010-02-24 — — EP disclosed
Send feedback